PubHawk
J Nanobiotechnology June 2023 PMID 37280622

Aptamer functionalized nucleic acid nano drug for targeted synergistic therapy for colon cancer.

Liye Zhu, Jieyu Yuhan, Hao Yu, Boyang Zhang, Longjiao Zhu, Xiaoyun He, Kunlun Huang, Wentao Xu

Download social card

Mentions

2
Peak: 1 in Jun 2023
across 2 sources since Jun 2023

Extended reach

302
potential audience

Total likes

0

Video views

6

Mentions per month

Jun 2023 – Sep 2023

Where it's discussed

  • X / Twitter1 posts
  • YouTube1 videos

AI synopsis

What people are saying

The discussions frequently praise the targeted specificity and potential of the nucleic acid nanosponges, with phrases like 'promising new approach' and 'revolutionizing cancer treatment,' indicating high interest. Some posts delve into methods used, such as aptamer targeting and apoptosis induction, reflecting moderate engagement. Overall, the enthusiasm for the research's potential impact is balanced by recognition of the need for further development.

AgreementModerate agreement

Most discussions show support for the potential benefits of targeted nanodrugs in colon cancer therapy, with some emphasizing its novelty and promise.

InterestHigh interest

Many posts express high curiosity and enthusiasm about the innovative approach and its implications for treatment, indicating strong interest.

EngagementModerate engagement

Several comments reference specific mechanisms, such as cell cycle arrest and apoptosis, showing a moderate level of detailed engagement.

ImpactModerate impact

While some discussions highlight the therapeutic potential, few elaborate on broader clinical or societal impacts, resulting in a moderate impact score.

Abstract in brief

  • The study developed a targeted nanosponges drug system (AS1411antimiR21Dox) using aptamers for precise delivery to colon cancer cells, addressing the complexity and metastasis issues of the disease.
  • The research demonstrated that this nucleic acid nanosponge induces cancer cell death by causing cell cycle arrest and apoptosis, as shown through various cellular analyses and transcriptomic studies.
  • Overall, the system offers an effective, customizable, and affordable approach for targeted colon cancer therapy by ensuring high payload efficiency and triggering specific mechanisms related to cell cycle disruption and apoptosis.]
Read the full abstract

Top posts

Most liked on X and Bluesky
Hammed Onilude (PhD)
@HammedOnilude · X

Aptamer functionalized nucleic acid nano drug for targeted synergistic therapy for colon cancer https://t.co/iOopVE3Dru

Jun 7, 2023 · 296 followers View post →

All mentions

Hammed Onilude (PhD)
@HammedOnilude · X

Aptamer functionalized nucleic acid nano drug for targeted synergistic therapy for colon cancer https://t.co/iOopVE3Dru

Jun 7, 2023 · 296 followers View post →